For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But ...

The decline of WeightWatchers is "more than just a business story", said Eva Wiseman in The Observer. It's a story about ...

A survey shows Gen Z favoring weight loss drugs like Ozempic and Wegovy over exercise and diet for reaching their weight loss ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

At its peak, WeightWatchers was seen as being synonymous with safe and controlled weight loss. With 4.5million subscribers ...

According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...

Every plus-sized woman I knew as a teenager would attend WeightWatchers in phases; they’d go, lose weight, leave, put the ...

WeightWatchers, officially rebranded as WW International ( NASDAQ: WW ), has blamed its financial woes on the GLP-1 drug wave ...

It changed the way we diet, but now Weight Watchers’ fortunes seem to be fading. Katie Rosseinsky explores how the Ozempic ...